Skip to main content
Clinical Trials/NCT05158400
NCT05158400UnknownNot Applicable

Diagnostic Value of Hand Ultrasound in Assessment of Rheumatoid Arthritis

Sohag University1 site in 1 country30 target enrollmentStarted: December 15, 2021Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Enrollment
30
Locations
1
Primary Endpoint
Diagnostic performance of Ultrasound in Rheumatoid Arthritis of the hand

Study Overview

Brief Summary

Rheumatoid arthritis (RA) is one of the most common autoimmune rheumatic diseases, affecting one in 100 individuals worldwide. It is considered a complex systemic multifactorial inflammatory process in which the immune system targets synovial joints and causes mild to severe joint destruction with extra-articular manifestations.

If left untreated, RA leads to deformity, considerable disability, and major comorbid conditions, including cardiovascular disease and increased mortality.

Early treatment with targeted therapies can alter long-term outcomes by minimizing disease activity, preventing joint damage and disability, and improving patients' quality of life.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Diagnostic
Masking
None

Eligibility Criteria

Ages
18 Years to 50 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Adult-onset disease.
  • Patients who fulfill the 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis.

Exclusion Criteria

  • Any patient with any collagen disease rather than Rheumatoid arthritis.
  • Patients with joints deformities.

Outcomes

Primary Outcomes

Diagnostic performance of Ultrasound in Rheumatoid Arthritis of the hand

Time Frame: 3 months

detecting hand ultrasound findings in 30 patients with clinical manifestations suggesting Rheumatoid Arthritis (including synovial thickening, joint effusion, tenosynovitis, bone erosions) particularly in early disease activity, reporting the collected data to assess aspects of strength and weakness of ultrasound use in those patients

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Fady Boles Anwer

resident doctor at Diagnostic and Interventional Radiology, Sohag university

Sohag University

Study Sites (1)

Loading locations...

Similar Trials